Karteek Popuri

Karteek Popuri

Auto-generated profile, based on publicly available information

Karteek Popuri

Department of Computer Science, Memorial University of Newfoundland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2020 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
KPKarteek Popuri
Karteek Popuri
DMDa Ma
Da Ma
LWLei Wang
Lei Wang
MBMirza Faisal Beg
Mirza Faisal Beg
Biomarkers for dementia of Alzheimer's type (DAT) are sought to facilitate accurate prediction of the disease onset, ideally predating the onset of cognitive deterioration. T1‐weighted magnetic resonance imaging (MRI) is a commonly used neuroimaging modality for measuring brain structure in vivo, potentially providing information enabling the design of biomarkers for DAT. We propose a novel biomarker using structural MRI volume‐based features to compute a similarity score for the individual's structural patterns relative to those observed in the DAT group. We employed ensemble‐learning framework that combines structural features in most discriminative ROIs to create an aggregate measure of neurodegeneration in the brain. This classifier is trained on 423 stable normal control (NC) and 330 DAT subjects, where clinical diagnosis is likely to have the highest certainty. Independent validation on 8,834 unseen images from ADNI, AIBL, OASIS, and MIRIAD Alzheimer's disease (AD) databases showed promising potential to predict the development of DAT depending on the time‐to‐conversion (TTC). Classification performance on stable versus progressive mild cognitive impairment (MCI) groups achieved an AUC of 0.81 for TTC of 6 months and 0.73 for TTC of up to 7 years, achieving state‐of‐the‐art results. The output score, indicating similarity to patterns seen in DAT, provides an intuitive measure of how closely the individual's brain features resemble the DAT group. This score can be used for assessing the presence of AD structural atrophy patterns in normal aging and MCI stages, as well as monitoring the progression of the individual's brain along with the disease course.

1 January 2018 in NeuroImage: Clinical
Verified
Journal Article
Open access
KPKarteek Popuri
Karteek Popuri
EDEmma Dowds
Emma Dowds
MBMirza Faisal Beg
Mirza Faisal Beg
RBRakesh Balachandar
Rakesh Balachandar
MBMahadev Bhalla
Mahadev Bhalla
GHGing-Yuek R. Hsiung
Ging-Yuek R. Hsiung
Frontotemporal dementia (FTD) is a neurodegenerative disease with a strong genetic basis. Understanding the structural brain changes during pre-symptomatic stages may allow for earlier diagnosis of patients suffering from FTD; therefore, we investigated asymptomatic members of FTD families with mutations in C9orf72 and granulin (GRN) genes. Clinically asymptomatic subjects from families with C9orf72 mutation (15 mutation carriers, C9orf72+; and 23 non-carriers, C9orf72-) and GRN mutations (9 mutation carriers, GRN+; and 15 non-carriers, GRN-) underwent structural neuroimaging (MRI). Cortical thickness and subcortical gray matter volumes were calculated using FreeSurfer. Group differences were evaluated, correcting for age, sex and years to mean age of disease onset within the subject's family. Mean age of C9orf72+ and C9orf72- were 42.6 ± 11.3 and 49.7 ± 15.5 years, respectively; while GRN+ and GRN- groups were 50.1 ± 8.7 and 53.2 ± 11.2 years respectively. The C9orf72+ group exhibited cortical thinning in the temporal, parietal and frontal regions, as well as reduced volumes of bilateral thalamus and left caudate compared to the entire group of mutation non-carriers (NC: C9orf72- and GRN- combined). In contrast, the GRN+ group did not show any significant differences compared to NC. C9orf72 mutation carriers demonstrate a pattern of reduced gray matter on MRI prior to symptom onset compared to GRN mutation carriers. These findings suggest that the preclinical course of FTD differs depending on the genetic basis and that the choice of neuroimaging biomarkers for FTD may need to take into account the specific genes involved in causing the disease.

5 October 2024 in Nutrition
Verified
Journal Article
Open access
MDMichelle V. Dietz
Michelle V. Dietz
KPKarteek Popuri
Karteek Popuri
LJLars Janssen
Lars Janssen
MSMushfiqus Salehin
Mushfiqus Salehin
DMDa Ma
Da Ma
JVJeroen L.A. van Vugt
Jeroen L.A. van Vugt
Body composition evaluation can be used to assess patients' nutritional status to predict clinical outcomes. To facilitate reliable and time-efficient body composition measurements eligible for clinical practice, fully automated computed tomography segmentation methods were developed. The aim of this study was to evaluate automated segmentation by Data Analysis Facilitation Suite in an independent dataset. Preoperative computed tomography images were used of 165 patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy from 2014 to 2019. Manual and automated measurements of skeletal muscle mass (SMM), visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intramuscular adipose tissue (IMAT) were performed at the third lumbar vertebra. Segmentation accuracy of automated measurements was assessed using the Jaccard index and intra-class correlation coefficients. Automatic segmentation provided accurate measurements compared to manual analysis, resulting in Jaccard score coefficients of 94.9 for SMM, 98.4 for VAT, 99.1 for SAT, and 79.4 for IMAT. Intra-class correlation coefficients ranged from 0.98 to 1.00. Automated measurements on average overestimated SMM and SAT areas compared to manual analysis, with mean differences (±2 standard deviations) of 1.10 (-1.91 to 4.11) and 1.61 (-2.26 to 5.48) respectively. For VAT and IMAT, automated measurements on average underestimated the areas with mean differences of -1.24 (-3.35 to 0.87) and -0.93 (-5.20 to 3.35), respectively. Commercially available Data Analysis Facilitation Suite provides similar results compared to manual measurements of body composition at the level of third lumbar vertebra. This software provides accurate and time-efficient body composition measurements, which is necessary for implementation in clinical practice.

28 May 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PSPrasanna Santhanam
Prasanna Santhanam
RDRoshan Dinparastisaleh
Roshan Dinparastisaleh
KPKarteek Popuri
Karteek Popuri
MBMirza Faisal Beg
Mirza Faisal Beg
SCStanley M. Chen Cardenas
Stanley M. Chen Cardenas
AHAmir Hamrahian
Amir Hamrahian
Determination of body composition (the relative distribution of fat, muscle, and bone) has been used effectively to assess the risk of progression and overall clinical outcomes in different malignancies. Sarcopenia (loss of muscle mass) is especially associated with poor clinical outcomes in cancer. However, estimation of muscle mass through CT scan has been a cumbersome, manually intensive process requiring accurate contouring through dedicated personnel hours. Recently, fully automated technologies that can determine body composition in minutes have been developed and shown to be highly accurate in determining muscle, bone, and fat mass. We employed a fully automated technology, and analyzed images from a publicly available cancer imaging archive dataset (TCIA) and a tertiary academic center. The results show that adrenocortical carcinomas (ACC) have relatively sarcopenia compared to benign adrenal lesions. In addition, functional ACCs have accelerated sarcopenia compared to non-functional ACCs. Further longitudinal research might shed further light on the relationship between body component distribution and ACC prognosis, which will help us incorporate more nutritional strategies in cancer therapy.

25 August 2025 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
MSMushfiqus Salehin
Mushfiqus Salehin
VCVincent Tze Yang Chow
Vincent Tze Yang Chow
HLHyunwoo Lee
Hyunwoo Lee
EWErin K. Weltzien
Erin K. Weltzien
LNLong Nguyen
Long Nguyen
KPKarteek Popuri
Karteek Popuri
Assessing body composition using computed tomography (CT) can help predict the clinical outcomes of cancer patients, including surgical complications, chemotherapy toxicity, and survival. However, manual segmentation of CT images is labor-intensive and can lead to significant inter-observer variability. In this study, we validate the accuracy and reliability of automatic CT-based segmentation using the Data Analysis Facilitation Suite (DAFS) Express software package, which rapidly segments single CT slices. The study analyzed single-slice images at the third lumbar vertebra (L3) level (n = 5973) of patients diagnosed with non-metastatic colorectal (n = 3098) and breast cancer (n = 2875) at Kaiser Permanente Northern California. Manual segmentation used SliceOmatic with Alberta protocol HU ranges; automated segmentation used DAFS Express with identical HU limits. The accuracy of the automated segmentation was evaluated using the DICE index, the reliability was assessed by intra-class correlation coefficients (ICC) with 95 % CI, and the agreement between automatic and manual segmentations was assessed by Bland-Altman analysis. DICE scores below 20 % and 70 % were considered failed and poor segmentations, respectively, and underwent additional review. The mortality risk associated with each tissue's area was generated using Cox proportional hazard ratios (HR) with 95 % CI, adjusted for patient-specific variables including age, sex, race/ethnicity, cancer stage and grade, treatment receipt, and smoking status. A blinded review process categorized images with various characteristics for sensitivity analysis. The mean (standard deviation, SD) ages of the colorectal and breast cancer patients were 62.6 (11.4) and 56 (11.8), respectively. Automatic segmentation showed high accuracy vs. manual segmentation, with mean DICE scores above 96 % for skeletal muscle (SKM), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT), and above 77 % for intermuscular adipose tissue (IMAT), with three failures, representing 0.05 % of the cohort. Bland-Altman analysis of 5973 measurements showed mean cross-sectional area differences of -5.73, -0.84, -2.82, and -1.02 cm2 for SKM, VAT, SAT and IMAT, respectively, indicating good agreement, with slight underestimation in SKM and SAT. Reliability Coefficients ranged from 0.88 to 1.00 for colorectal and 0.95-1.00 for breast cancer, with Simple Kappa values of 0.65-0.99 and 0.67-0.97, respectively. Additionally, mortality associations for automated and manual segmentations were similar, with comparable hazard ratios, confidence intervals, and p-values. Kaplan-Meier survival estimates showed mortality differences below 2.14 %. DAFS Express enables rapid, accurate body composition analysis by automating segmentation, reducing expert time and computational burden. This rapid analysis of body composition is a prerequisite to large-scale research that could potentially enable use in the clinical setting. Automated CT segmentations may be utilized to assess markers of sarcopenia, muscle loss, and adiposity and predict clinical outcomes.

20 September 2025 in ACM Transactions on Design Automation of Electronic Systems
Verified
Journal Article
Open access
MGMorteza Golzan
Morteza Golzan
TNTelex Magloire Ngatched Nkouatchah
Telex Magloire Ngatched Nkouatchah
KPKarteek Popuri
Karteek Popuri
Lihong ZhangLihong Zhang
Lihong Zhang
The design of circuits and systems has witnessed a growing interest in leveraging the potential of artificial intelligence in the realm of analog and mixed-signal (AMS) integrated circuits (ICs). This article presents a comprehensive survey on the application of machine learning techniques to the modeling and optimization of AMS ICs and systems. We explore the state-of-the-art research subjects in this domain and identify the advancements made in automating AMS performance modeling and optimization pursuit from a machine learning perspective. We propose to categorize the existing endeavors in the literature from four points of view (i.e., modeling, optimization, structure, and application). By analyzing the existing methods and discussing their advantages as well as limitations, we aim to shed light on the challenges and opportunities in empowering machine learning for tackling more complex AMS IC and system designs.